Subject Matter Expertise
HOPA takes pride in our members and their valuable contributions to the field of hematology/oncology pharmacy. See some of our member-experts in action below.
Experts: The Hematology-Oncology Pharmacist Great Migration Is Caused by Issues Outside of Burnout That Could Be Quickly Addressed
Zahra Mahmoudjafari, PharmD, BCOP, DPLA; Alison Gulbis, PharmD, BCOP; and Kamakshi Rao, PharmD, BCOP, FASHP, discuss the underlying causes of the hematology-oncology pharmacist great migration from the field.
National Survey on the Effect of Oncology Drug Shortages in Clinical Practice: A Hematology Oncology Pharmacy Association Survey
Ali McBride , PharmD1,2; Sarah Hudson-DiSalle, PharmD3; Jeff Pilz , PharmD3; Mark Hamm, PharmD4; Brooke Boring, MPH5; Larry W. Buie, PharmD6; and David L. DeRemer , PharmD7,8
The purpose of this survey was to characterize the impact of oncology drug shortages across the United States, including the experiences of health care organizations, resource implications, and the impact on patient safety, patient care, and clinical trials.
Experts discuss insight from a recently published oncology drug shortages research project and HOPA’s plan to address related issues based on the project’s findings.
Pharmacy Times interviewed Sarah Hudson-Disalle, PharmD, RPh, pharmacy manager in the Department of Pharmacy at the Ohio State Wexner Medical Center and chair of the Public Policy Committee at the Hematology/Oncology Pharmacy Association (HOPA), and Jeffrey Pilz, PharmD, MPA, MS, BCPS, assistant director of pharmacy – medication safety and drug policy in the Department of Pharmacy at the Ohio State Wexner Medical Center and vice chair of the Public Policy Committee at the HOPA, on HOPA’s oncology drug shortages research project.
